NoWay
It's time to play the game
Royal Dutch Shell Q221 Earnings: Revenue: USD61.76B Adj EPS: 71C (est 61C) Share Buybacks Of USD2B Launched Today; Target Completion End Of Year Adj Operating Profit: USD5.53B (est USD5.20B) Div/Share: 24C
Anglo American H1 Earnings: Revenue: USD21.78B Adj EBITDA: USD12.14B (est USD11.57B) Adj Profit: USD5.34B (est USD4.75B) Adj EPS: USD4.30 (est USD3.83) To Pay USD4.1B In Interim Dividend, Extra Return, Buyback Declares: USD80 Special Dividend
Lloyds Banking Group Q221 Earnings: Net Interest Income: GBP2.74B (est GBP2.71B) Statutory Pretax Profit: GBP2.01B (est GBP1.40B) ROTE: +24.45 Net Interest Margin: 2.51% (est 2.49%) Purchase Of Embark Group Interim Ordinary Div Of 0.67P/Share
BAE Systems Q221 Earnings: Sales: GBP10.04B (est GBP9.93B) Underlying EBIT: GBP1.03B Adj EPS: 21.9P (est 20.3P) Interim Div/Share: 9.9P (vs. 9.4P Y/Y)
AstraZeneca Q221 Earnings: Revenue: USD8.22B (est USD7.39B) Revenue Ex Covid Vaccine: USD7.33B (est USD7.39B) Core EPS: 90C (est 92C) Interim Div/Share: 90C Sees FY Core EPS: USD5.05 To USD5.40 (est USD5.14)
Anglo American H1 Earnings: Revenue: USD21.78B Adj EBITDA: USD12.14B (est USD11.57B) Adj Profit: USD5.34B (est USD4.75B) Adj EPS: USD4.30 (est USD3.83) To Pay USD4.1B In Interim Dividend, Extra Return, Buyback Declares: USD80 Special Dividend
Lloyds Banking Group Q221 Earnings: Net Interest Income: GBP2.74B (est GBP2.71B) Statutory Pretax Profit: GBP2.01B (est GBP1.40B) ROTE: +24.45 Net Interest Margin: 2.51% (est 2.49%) Purchase Of Embark Group Interim Ordinary Div Of 0.67P/Share
BAE Systems Q221 Earnings: Sales: GBP10.04B (est GBP9.93B) Underlying EBIT: GBP1.03B Adj EPS: 21.9P (est 20.3P) Interim Div/Share: 9.9P (vs. 9.4P Y/Y)
AstraZeneca Q221 Earnings: Revenue: USD8.22B (est USD7.39B) Revenue Ex Covid Vaccine: USD7.33B (est USD7.39B) Core EPS: 90C (est 92C) Interim Div/Share: 90C Sees FY Core EPS: USD5.05 To USD5.40 (est USD5.14)